Enhancement of non-specific immune defenses by administration of

Details Enhancement of non-specific immune defenses by administration of Enhancement of non-specific immune defenses by administration of

1995-03-08

1998-12-15

Kiaht, John

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514885, 536114, 536121, 536123, 536124, 53612312, 435101, 4352552, A61K 31715

Patent

active

058497200

ABSTRACT:
A method for producing soluble preparations of neutral glucan polymers is disclosed. The method involves treating whole glucan particles with a unique sequence of acid and alkaline treatments to produce soluble glucan. The soluble glucan can be purified to obtain a physiologically acceptable solution of neutral glucan molecules. A soluble neutral glucan preparation is obtained which forms a clear solution at a neutral pH and is equilibrated in a pharmaceutically acceptable carrier.

REFERENCES:
patent: 3943247 (1976-03-01), Komatsu et al.
patent: 4138479 (1979-02-01), Truscheit et al.
patent: 4237266 (1980-12-01), Sugiura et al.
patent: 4707471 (1987-11-01), Larm et al.
patent: 4739046 (1988-04-01), DiLuzio et al.
patent: 4761402 (1988-08-01), Williams et al.
patent: 4810646 (1989-03-01), Jamas et al.
patent: 4946450 (1990-08-01), Erwin
patent: 4975421 (1990-12-01), Williams et al.
patent: 5032401 (1991-07-01), Jamas et al.
patent: 5057503 (1991-10-01), Czop et al.
patent: 5320849 (1994-06-01), Hagiwara et al.
patent: 5322841 (1994-06-01), Jamas et al.
patent: 5401647 (1995-03-01), Tanaka et al.
patent: 5448040 (1995-09-01), Jamas et al.
patent: 5474984 (1995-12-01), Tanaka et al.
patent: 5504079 (1996-04-01), Jamas et al.
Vestnik Federalniho Uradu Pro Vynalezy, 10:111 (1989).
Vestnik Federalniho Uradu Pro Vynalezy, 11:122-123 (1989).
Chihara, G., et al., "Lentinan as a Host Defense Potentiator (HPD)," Int. J. Immunotherapy, V(4):15-154 (1989).
Sherwood, E.R., et al., "Enhancement of Interleukin-1 and Interleukin-2 Production by Soluble Glucan," Int. J. Immunopharmac., 9(3):261-267 (1987).
Williams, D.L., et al., "Pre-clinical Safety Evaluation of Soluble Glucan," Int. J. Immunopharmac., 10(4):405-414 (1988).
Sasaki et al., "Antitumor Activity of Degraded Products of Lentinan: Its Correlation with Molecular Weight," Gann(Japanese J. Cancer Res.), 67(2), 191-195 (Apr. 1976).
DiLuzio et al., "Comparative tumor-Inhibitory and Antibacterial Activity of Soluble and Particulate Glucan (Immuno therapeutic Activity of Soluble Glucan)," Int. J. Cancer, 24, 773-779 (1979).
Burgaleta et al., "Effect of Glucan on Granulopoiesis and Macrophage Genesis in Mice," Cancer Research, 37, 1739-1742 (Jun. 1977).
Kenyon, "delayed Wound Healing in Mice Associated with Viral Alteration of Macrophages," Am. J. Vet. Res., 44(4), 652-656 (Apr. 1983).
Hobart et al., A Course on the Molecular and Cellular Basis of Immunity, Blackwell Scientific Publications, Oxford, UK, (Revised Reprint, 1976), only pp. 317-332 supplied.
Vila et al., "Absence of Viral Rebound After Treatment of HIV-Infected Lancet, 350(9078), 635-636 (Aug. 30, 1997).
Janusz, M.J. et al., "Isolation of Soluble Yeast .beta.-Glucans that Inhibit Human Monocyte Phagocytosis Mediated By .beta.-Glucan Receptors", J. Immunol. 137:3270-3276 (1986).
Manners, D.J. et al., "the Structure of a .beta.-(1-3)-D-Glucan From Yeast Cell Walls", Biochem. J. 135:19-30 (1973).
Williams, D.L. et al., "Pre-Clinical Safety Evaluation of Soluble Glucan", Chemical Abstracts 109:66566q (1988).
Fleet, G.H. et al., "Isolation and Composition of an alkali-soluble Glucan from the Cell Walls of Saccharomyces cerevisiae", Chemical Abstracts 85:89819z (1976).
Bacon, J. et al., "The Glucan Components of the Cell Wall of Baker's Yeast (Saccharomyces cerevisiae) Considered in Relation to its Ultrastructure", Biochem. J. 114:557-567 (1969).
Fleet, G. H. et al., "Isolation and Composition of an Alkali-Soluble Glucan from the Cell Walls of Saccharomyces cerevisiae", Journal of General Microbiology 94:180-192 (1976.
Latge, J.P., et al., "Composition Chimique et Ultrastructure des Parois des Corps Hyphaux et des Azygospores de Conidiobolus obscurus", Can. J. Microbiol. 30:1507-1521 (1984).
Hara, C., et al., "A Branched (1-3)-.beta.-D-Glucan from a Water Extract of Dictyophora indusiata FISCH", Carbohydrate Research 145:237-246 (1986).
Goldman, R., "Induction of a .beta.-1,3-D-Glucan Receptor in P388D1 Cells Treated with Retinoic Acit or 1,25-dihydroxyvitamin D.sub.3 ", Immunology 63:319-324 (1988).
Sherwood et al., "Soluble Glucan and Lymphokine-Activated Killer (LAK) Cells in the Therapy of Experimental Hepatic Metastases", Chemical Abstracts 108:179752V (1988).
Konopski, Z. et al., "Phagocytosis of .beta.-1,3-D-Glucan-Derivatized Microbeads by Mouse Peritoneal Macrophages Involves Three Different Receptors", Scand. J. Immuno. 33:297-306 (1991).
Reinskind, J.B. et al., "Molecular Architecture of the Hyphal Wall of Achiya ambisexualis Raper. II Ultrastructural Analyses and a Proposed Model", Can J. Microbiol. 27:1100-1105 (1981).
Miyazaki et al., "Structural Examination of Antiturmour, Water-Soluble Glucans from Grifora umbellata by Use of Four types of Glucanase", Carbohydrate Research 65:232-243 (1978).
Shiota et al., "Comparison of .beta.-Glucan Structures in a Cell Wall Mutant of Saccharomyces cerevisiae and the wild type", J.Biochem. 98:1301-1307 (1985).

Affiliated with

Also associated with

Rating

Enhancement of non-specific immune defenses by administration of does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enhancement of non-specific immune defenses by administration of, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancement of non-specific immune defenses by administration of will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1458000